ConductScience.org, home

Paper40765720

Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions.

Hamilton JL and 3 others. Alzheimers Dement (N Y), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions. Papers, record 40765720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40765720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions.
PubMed
Journal
Alzheimers Dement (N Y)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-09-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamilton JLJamie L
2Fuller RLMRebecca L M
3Modi NNoopur
4Sampaio CCristinahttps://orcid.org/0000-0002-7052-9079

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136641605Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease.J Prev Alzheimers Dis2023https://conductscience.org/library/papers/36641605PubMed
232317262Outcomes tested in non-pharmacological interventions in mild cognitive impairment and mild dementia: a scoping review.BMJ Open2020https://conductscience.org/library/papers/32317262PubMed
337147862Defining Clinical Meaningfulness in Huntington's Disease.Mov Disord2023https://conductscience.org/library/papers/37147862PubMed
432432155Composite cognitive and functional measures for early stage Alzheimer's disease trials.Alzheimers Dement (Amst)2020https://conductscience.org/library/papers/32432155PubMed
517136977Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs).COPD2005https://conductscience.org/library/papers/17136977PubMed
619187414Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.J Am Geriatr Soc2009https://conductscience.org/library/papers/19187414PubMed
733208190Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.Alzheimers Res Ther2020https://conductscience.org/library/papers/33208190PubMed
823507773Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.J Alzheimers Dis2013https://conductscience.org/library/papers/23507773PubMed
933783469Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.JAMA2021https://conductscience.org/library/papers/33783469PubMed
1017034633Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.Health Qual Life Outcomes2006https://conductscience.org/library/papers/17034633PubMed
1118695059Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.Arch Neurol2008https://conductscience.org/library/papers/18695059PubMed
1238561021Minimal clinically important difference in Alzheimer's disease: Rapid review.Alzheimers Dement2024https://conductscience.org/library/papers/38561021PubMed
1340765720Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions.Alzheimers Dement (N Y)2025https://conductscience.org/library/papers/40765720PubMed
1437521521Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary.Alzheimers Dement (N Y)2023https://conductscience.org/library/papers/37521521PubMed
151202204"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res1975https://conductscience.org/library/papers/1202204PubMed
169626712Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.Psychol Med1998https://conductscience.org/library/papers/9626712PubMed
1734087114The need to show minimum clinically important differences in Alzheimer's disease trials.Lancet Psychiatry2021https://conductscience.org/library/papers/34087114PubMed
1830661630Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.Value Health2019https://conductscience.org/library/papers/30661630PubMed
1935676941Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates.Alzheimers Dement (N Y)2022https://conductscience.org/library/papers/35676941PubMed
2028662127Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.PLoS One2017https://conductscience.org/library/papers/28662127PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42426363Defining and Measuring Cognitive Decline and Clinical Relevance.Neurol Ther2026https://conductscience.org/library/papers/42426363PubMed
42233248Validity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population.Alzheimers Dement2026https://conductscience.org/library/papers/42233248PubMed
42098470Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis.Arch Pharm Res2026https://conductscience.org/library/papers/42098470PubMed
40765720Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions.Alzheimers Dement (N Y)2025https://conductscience.org/library/papers/40765720PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40765720

GET https://conductscience.org/api/papers/v1/40765720/references?page=2